Cargando…

马法兰替代环磷酰胺的预处理方案在异基因造血干细胞移植治疗恶性髓系血液病的临床研究

OBJECTIVE: To evaluate melphalan instead of cyclophosphamide in modified busulfancyclophosphamide regimen as a new myeloablative conditioning regimen for the treatment of myeloid malignancies patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). METHODS: The clinic data of 94...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364934/
https://www.ncbi.nlm.nih.gov/pubmed/26477761
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2015.10.006